Quantcast

Latest carcinoid syndrome Stories

2015-03-18 08:29:21

-- Lexicon eligible for an additional $5 million in up-front and pre-commercial milestone payments for Canadian rights, plus royalties and sales milestones under original agreement --

2015-03-09 08:29:26

Top-Line Results Expected in the 3rd Quarter of 2015 THE WOODLANDS, Texas, March 9, 2015 /PRNewswire/ -- Lexicon

2015-02-23 16:31:27

THE WOODLANDS, Texas, Feb.

2014-11-04 16:28:36

Focus on the Completion of Phase 3 Clinical Trials and Commercial Preparations for Telotristat Etiprate in Carcinoid Syndrome THE WOODLANDS, Texas, Nov.

2014-10-22 00:21:42

-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct.

2014-02-28 08:24:53

Conference Call and Webcast at 11:00 a.m. Eastern Time THE WOODLANDS, Texas, Feb.

2014-01-29 16:29:03

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q8l6jf/lexicons) has announced the addition of the "Lexicon's

2014-01-13 08:26:10

New Phase in Company Evolution from Genetics to Therapies THE WOODLANDS, Texas, Jan.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related